CTKB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cytek Biosciences Inc

Watchlist Manager

Watchlist

Price: 4.02 USD -0.74% Market Closed

Market Cap: $519.1m

	Cytek Biosciences Inc NASDAQ:CTKB	US
	Hitachi Ltd TSE:6501	JP
T	thyssenkrupp nucera AG & Co KgaA XETRA:NCH2	DE
C	Christian Dior SE OTC:CHDRY	FR
	SK Inc KRX:034730	KR
	Olaplex Holdings Inc NASDAQ:OLPX	US

Profitability Summary

Cytek Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

52%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

61% > 52%

Negative Operating Margin

-20%

Negative 3Y Average Operating Margin

-14%

Declining Operating Margin

-7% > -20%

Negative Net Margin

-33%

Negative 3Y Average Net Margin

-8%

Declining Net Margin

-1% > -33%

Negative Free Cash Flow Margin

-4%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-11% > -4%

Negative ROE

-18%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-14%

Declining ROIC

-3% > -44%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

52%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

61% > 52%

Negative Operating Margin

-20%

Negative 3Y Average Operating Margin

-14%

Declining Operating Margin

-7% > -20%